Matrix Metalloproteinase Suppression Induced by Clarithromycin in Murine Cardiac Allografts

Transplantation Proceedings

Volumn 41, Issue 1, 2009, Pages 395-397

  Ogawa, M ^a   Suzuki, J ^a,b   Takayama, K ^a   Isobe, M ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CLARITHROMYCIN; DRUG VEHICLE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MATRIX METALLOPROTEINASE;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CELL INFILTRATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; HEART MUSCLE CELL; HEART TRANSPLANTATION; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD4; ANTIGENS, CD8; CLARITHROMYCIN; GELATINASES; GRAFT REJECTION; HEART TRANSPLANTATION; INTERCELLULAR ADHESION MOLECULE-1; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NF-KAPPA B; SUPPRESSION, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 60649100035     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.10.057     Document Type: Article

References (20)

1. Kikuchi T., Hagiwara K., Honda Y., et al. Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors. J Antimicrob Chemother 49 (2002) 745
2. Abe S., Nakamura H., Inoue S., et al. Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. Am J Respir Cell Mol Biol 22 (2000) 51
3. Leppert D., Waubant E., Galardy R., et al. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 154 (1995) 4379
4. Xia M., Leppert D., Hauser S.L., et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol 156 (1996) 160
5. Hibbs M.S., Hoidal J.R., and Kang A.H. Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest 80 (1987) 1644
6. Hashimoto N., Kawabe T., Hara T., et al. Effect of erythromycin on matrix metalloproteinase-9 and cell migration. J Lab Clin Med 137 (2001) 176
7. Ermolli M., Schumacher M., Lods N., et al. Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection. Transpl Immunol 11 (2003) 137
8. Suzuki J., Isobe M., Kawauchi M., et al. Altered expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in acutely rejected myocardium and coronary arteriosclerosis in cardiac allografts of nonhuman primates. Transpl Int 13 (2000) 106
9. Yamani M.H., Starling R.C., Young J.B., et al. Acute vascular rejection is associated with up-regulation of vitronectin receptor (alphavbeta3), increased expression of tissue factor, and activation of the extracellular matrix metalloproteinase induction system. J Heart Lung Transplant 21 (2002) 983
10. Cho A., and Reidy M.A. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 91 (2002) 845
11. Mason D.P., Kenagy R.D., Hasenstab D., et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 85 (1999) 1179
12. Suzuki M.J., Ogawa M., Sagesaka Y.M., et al. Tea catechins attenuate ventricular remodeling and graft arterial diseases in murine cardiac allografts. Cardiovasc Res 69 (2006) 272
13. Tessier M.P.R., Kim M.K., Zhou W., et al. Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia. Antimicrob Agents Chemother 46 (2002) 1425
14. Vallee E., Azoulay-Dupuis E., Swanson R., et al. Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection. J Antimicrob Chemother 27 suppl A (1991) 31
15. Suzuki J., Koga N., Kosuge H., et al. Pitavastatin suppresses acute and chronic rejection in murine cardiac allografts. Transplantation 83 (2007) 1093
16. Kosuge H., Haraguchi G., Koga N., et al. Pioglitazone prevents acute and chronic cardiac allograft rejection. Circulation 113 (2006) 2613
17. Ogawa M., Suzuki J., Hishikari K., et al. Clarithromycin attenuates acute and chronic rejection via MMP suppression in murine cardiac transplantation. J Am Coll Cardiol 51 (2008) 1977
18. Giannelli G., Falk-Marzillier J., Schiraldi O., et al. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277 (1997) 225
19. Dubois B., Masure S., Hurtenbach U., et al. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest 104 (1999) 1507
20. Li Q., and Verma I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2 (2002) 725